You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Could Dedicated Breast PET Predict Multifocality?

    SBC: NAVISCAN PET SYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): A two-phase study is planned to validate whether functional breast imaging with a dedicated breast PET device could detect and confirm breast cancer multifocality and/or multicentricity prior to surgery. Surgeons ar

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  2. Fatty Acid Synthase Inhibitors: Ovarian Cancer Therapy

    SBC: FASGEN, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Phase I Ovarian cancer is the fifth leading cause of cancer death among U.S. women and has the highest mortality rate of all gynecologic cancers, with 23,400 new cases and 13,900 deaths projected in 2001. Screening

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  3. Accuracy of Diffuse Optical Tomography Using 3d camera

    SBC: TECHNEST, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Phase I The primary objective of the SBR effort proposed herein is to investigate the feasibility of significantly enhancing the imaging capacity of diffuse optical tomography (DOT) technology by using a novel 3D ima

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  4. Transcutaneous Immunization for an Anthrax Vaccine

    SBC: IOMAI CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Vaccination plays a central role in a biodefense strategy and is the established intervention against anthrax. Further development of both existing and new biodefense vaccines is required to improve the anthrax va

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  5. Robust Missing Data Methods for Categorical Regression

    SBC: MARTINGALE RESEARCH CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Improved methods for obtaining robust statistical inferences from categorical regression models in the presence of missing data and model misspecification would be an invaluable tool to the epidemiological and health c

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  6. MRI-enhanced Endoscopy with tracking-imaging probes

    SBC: ROBIN MEDICAL INC            Topic: N/A

    DESCRIPTION (provided by applicant): The Phase-II project aims to develop tracking and imaging probe (TIP) for MR-enhanced endoscopy. MRI has many advantages over traditional optical and ultrasound endoscopy, such as excellent soft tissue contrast an

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  7. Use of Mouse Chimeras to Test Gene Function

    SBC: MUSWORKS, INC.            Topic: N/A

    The commercial objective of MusWorks Inc. is to provide a mouse aggregation chimera production service to the biomedical research community. Mouse chimeras are genetically composite animals whose cells are derived from different embryos. Chimera analysis

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  8. Neutron Detector for Protein Crystallography

    SBC: PROPORTIONAL TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Improved understanding of the three-dimensional structure of proteins is of well-recognized value in the treatment of disease and in the development of new therapeutic drugs. Precise measurement of hydrogen atom posit

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  9. HIV-1 vector mediated gene therapy for HIV-1 infection

    SBC: VIRXSYS CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): HIV infects 40 million people worldwide. In the United States (U.S.), it is estimated that almost one million people are infected with HIV. The mortality due to HIV/AIDS is estimated to be approximately three (3) m

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  10. Surgical Monitor for Detection of Spinal Cord Injury

    SBC: INFINITE BIOMEDICAL TECHNOLOGIES, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Somatosensory evoked potential (SEP) monitoring during spinal surgery has been associated with a 61% reduction in major neurological deficits. However, visual interpretation of signals is not always accurate, and a

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government